Semaglutide is a synthetic analog of glucagon-like peptide-1 (GLP-1), extensively studied in laboratory settings for its potential roles in glucose metabolism, insulin secretion, and appetite modulation. Laboratory research involving Semaglutide investigates its impact on gastric emptying, satiety signaling, and metabolic pathways related to weight management and energy balance. Studies indicate Semaglutide may significantly influence appetite and glucose homeostasis via interactions with GLP-1 receptors.

Scientific investigations continue to evaluate Semaglutide’s potential roles in metabolic regulation, obesity research, cardiovascular health, and neurodegenerative processes in controlled laboratory environments.

Important Notice: This product is intended strictly for research purposes only. It is not approved by the FDA and is not intended for human or animal consumption, nor for diagnostic, therapeutic, or clinical applications. Usage of Semaglutide outside laboratory research settings violates sections 505(a) and 301(d) of the Federal Food, Drug, and Cosmetic Act (FD&C Act), 21 U.S.C. §§ 355(a) and 331(d).

Product Specifications:

• Purity: ≥99% (HPLC verified)
• Formulation: Lyophilized powder
• Molecular Formula: C₁₈₇H₂₉₁N₄₅O₅₉
• Molecular Weight: 4113.6 g/mol
• CAS Number: 910463-68-2

Source: PubChem